FUSN Annual SG&A
$31.20 M
+$597.00 K+1.95%
31 December 2023
Summary:
As of February 5, 2025, FUSN annual selling, general & administrative expenses is $31.20 million, with the most recent change of +$597.00 thousand (+1.95%) on December 31, 2023. During the last 3 years, it has risen by +$10.45 million (+50.39%).FUSN Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FUSN Quarterly SG&A
$14.55 M
+$6.92 M+90.72%
31 March 2024
Summary:
As of February 5, 2025, FUSN quarterly selling, general & administrative expenses is $14.55 million, with the most recent change of +$6.92 million (+90.72%) on March 31, 2024. Over the past year, it has increased by +$7.74 million (+113.63%).FUSN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FUSN TTM SG&A
-$1.47 B
-$104.28 M-7.65%
31 March 2024
Summary:
As of February 5, 2025, FUSN TTM selling, general & administrative expenses is -$1.47 billion, with the most recent change of -$104.28 million (-7.65%) on March 31, 2024. Over the past year, it has dropped by -$1.50 billion (-4907.16%).FUSN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FUSN Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.9% | +113.6% | -4907.2% |
| 3 y3 years | +50.4% | +113.6% | -4907.2% |
| 5 y5 years | +869.5% | +113.6% | -4907.2% |
FUSN Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -89.5% | -439.7% |
Fusion Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $14.55 M(+90.7%) | $36.74 M(+17.8%) |
| Dec 2023 | $31.20 M(+2.0%) | $7.63 M(+12.0%) | $31.20 M(+2.2%) |
| Sept 2023 | - | $6.81 M(-12.2%) | $30.52 M(-2.0%) |
| June 2023 | - | $7.75 M(-13.9%) | $31.13 M(-0.1%) |
| Mar 2023 | - | $9.01 M(+29.6%) | $31.16 M(+1.8%) |
| Dec 2022 | $30.60 M(+12.9%) | $6.95 M(-6.3%) | $30.60 M(+2.0%) |
| Sept 2022 | - | $7.42 M(-4.6%) | $29.99 M(+0.9%) |
| June 2022 | - | $7.78 M(-7.9%) | $29.72 M(+4.0%) |
| Mar 2022 | - | $8.45 M(+33.3%) | $28.58 M(+5.5%) |
| Dec 2021 | $27.10 M(+30.6%) | $6.34 M(-11.5%) | $27.10 M(-1.1%) |
| Sept 2021 | - | $7.16 M(+7.7%) | $27.40 M(+5.2%) |
| June 2021 | - | $6.64 M(-4.6%) | $26.04 M(+11.4%) |
| Mar 2021 | - | $6.96 M(+4.9%) | $23.38 M(+12.7%) |
| Dec 2020 | $20.74 M | $6.64 M(+14.7%) | $20.74 M(+23.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $5.79 M(+45.2%) | $16.83 M(+29.8%) |
| June 2020 | - | $3.99 M(-7.8%) | $12.96 M(+20.6%) |
| Mar 2020 | - | $4.33 M(+58.8%) | $10.74 M(+41.6%) |
| Dec 2019 | $7.59 M(+135.8%) | $2.72 M(+41.7%) | $7.59 M(-92.4%) |
| Sept 2019 | - | $1.92 M(+8.5%) | $100.10 M(-57.6%) |
| June 2019 | - | $1.77 M(+51.2%) | $236.35 M(-30.8%) |
| Mar 2019 | - | $1.17 M(-98.8%) | $341.65 M(-20.9%) |
| Dec 2018 | $3.22 M(+98.6%) | - | - |
| Dec 2018 | - | $95.24 M(-31.1%) | $431.88 M(+2.5%) |
| Sept 2018 | - | $138.17 M(+29.1%) | $421.37 M(+18.8%) |
| June 2018 | - | $107.07 M(+17.1%) | $354.75 M(+43.2%) |
| Mar 2018 | - | $91.40 M(+7.9%) | $247.69 M(+58.5%) |
| Dec 2017 | $1.62 M | - | - |
| Dec 2017 | - | $84.73 M(+18.4%) | $156.29 M(+118.4%) |
| Sept 2017 | - | $71.56 M | $71.56 M |
FAQ
- What is Fusion Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals annual SG&A year-on-year change?
- What is Fusion Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals quarterly SG&A year-on-year change?
- What is Fusion Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals TTM SG&A year-on-year change?
What is Fusion Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of FUSN is $31.20 M
What is the all time high annual SG&A for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high annual selling, general & administrative expenses is $31.20 M
What is Fusion Pharmaceuticals annual SG&A year-on-year change?
Over the past year, FUSN annual selling, general & administrative expenses has changed by +$597.00 K (+1.95%)
What is Fusion Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of FUSN is $14.55 M
What is the all time high quarterly SG&A for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $138.17 M
What is Fusion Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, FUSN quarterly selling, general & administrative expenses has changed by +$7.74 M (+113.63%)
What is Fusion Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of FUSN is -$1.47 B
What is the all time high TTM SG&A for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high TTM selling, general & administrative expenses is $431.88 M
What is Fusion Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, FUSN TTM selling, general & administrative expenses has changed by -$1.50 B (-4907.16%)